Nadav Kidron, President and CEO, 10% Owner at ORAMED PHARMACEUTICALS INC. (ORMP), bought 122 shares at $5.92 ($722) on 2018-07-11, disclosed to the SEC on 2018-07-12.
Open-market purchase of $722 ORMP by President and CEO, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| Filing → |
| ORMP | SELL | 2021-08-11 | $4.4M | — | Filing → |
| ORMP | BUY | 2016-05-12 | $7K | — | Filing → |
| ORMP | BUY | 2015-05-12 | $4K | — | Filing → |